BioSpace News Archive

HIV/AIDS Diagnostics Market to Witness an Outstanding Growth by 2027

HIV (Human Immunodeficiency Virus) and AIDS (Acquired Immune Deficiency Syndrome) are global health problems. As such, there is growing demand to improve the effectiveness and simplify tests for HIV diagnostics, without compromising on the patient’s quality of life.

August 29, 2022
·
9 min read
Hemostats (Tissue Sealants, Tissue Adhesives and Adhesion Prevention Products) Market Competitive Research and Precise Outlook 2021 to 2031

The increasing incidence of cardiovascular ailments as well as certain chronic diseases such as cancer, is leading to considerable growth in the surgical procedures around the globe.

August 29, 2022
·
11 min read
Exanthema Market to Reflect Impressive Growth Rate During 2021-2031

Exanthema is a skin issue resulting in rashes and affects children.

August 29, 2022
·
6 min read
Bio NC

Verona Pharma to Present at H.C. Wainwright 24th Annual Global Investment Conference

Verona Pharma plc, announces that senior management will present a company overview at the H.C. Wainwright 24th Annual Global Investment Conference on Monday, September 12, 2022 at 2:00 PM ET / 7:00 PM BST.

August 29, 2022
·
1 min read
Business

RaySearch Laboratories: Interim report April 1 - June 30, 2022

RaySearch signed an agreement with Region Västerbotten to provide RayStation to Norrlands universitetssjukhus.

August 29, 2022
·
3 min read
Drug Development

Sirnaomics Achieves 100% Complete Response in Phase II Clinical Trial of STP705 for Treatment of Cutaneous Basal Cell Carcinoma

Sirnaomics Ltd. announced that the cohort receiving the 180μg dose level in the Phase II clinical trial of STP705 for the treatment of cutaneous basal cell carcinoma achieved a 100% complete response, indicating the promising viability of the treatment.

August 29, 2022
·
5 min read
Business

Horizon Therapeutics plc Announces Plans to Expand its Development and Manufacturing Facility in Waterford, Ireland

Horizon Therapeutics plc announced it submitted a planning application to expand its development and manufacturing facility in Waterford, Ireland to add new drug substance biologics development and manufacturing capabilities.

August 29, 2022
·
3 min read
Policy

Galaxy Medical Receives CE Mark for CENTAURI Pulsed Electric Field System

Galaxy Medical announced that it received the CE Mark for its CENTAURI Pulsed Electric Field System and launched its commercial program.

August 29, 2022
·
3 min read
Genetown

Swissmedic Authorizes Moderna’s Omicron-Targeting Bivalent Booster Candidate, MRNA-1273.214

Moderna, Inc. announced that Swissmedic has granted temporary authorization for the use of Moderna’s Omicron-targeting bivalent booster vaccine, Spikevax Bivalent Original/Omicron for active immunization to prevent SARS-CoV-2 virus-induced Coronavirus-2019 disease for individuals aged 18 years and older.

August 29, 2022
·
5 min read
BioMidwest

ANI Pharmaceuticals Announces the Launch of Prochlorperazine Maleate Tablets USP

ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced the launch of Prochlorperazine Maleate Tablets USP, 5 mg and 10 mg.

August 29, 2022
·
3 min read